Holen Sie sich die Stockscreener-App
0.6706
0.62%
0.0041
Handel nachbörslich:
.67
-0.0006
-0.09%
Schlusskurs vom Vortag:
$0.6665
Offen:
$0.68
24-Stunden-Volumen:
86,759
Relative Volume:
0.23
Marktkapitalisierung:
$51.65M
Einnahmen:
$234.00K
Nettoeinkommen (Verlust:
$-23.11M
KGV:
-0.6516
EPS:
-1.0292
Netto-Cashflow:
$-20.71M
1W Leistung:
+1.19%
1M Leistung:
-15.33%
6M Leistung:
+3.19%
1J Leistung:
-54.07%
1-Tages-Spanne:
$0.6503
$0.6812
1-Wochen-Bereich:
$0.6229
$0.70
52-Wochen-Spanne:
$0.3625
$1.89
Envoy Medical Inc Stock (COCH) Company Profile
Firmenname
Envoy Medical Inc
Sektor
Branche
Telefon
651-361-8000
Adresse
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.6706 | 51.91M | 234.00K | -23.11M | -20.71M | -1.0292 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-24 | Eingeleitet | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Aktie (COCH) Neueste Nachrichten
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCHW - TradingView
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCH - TradingView
Envoy Medical Inc (COCH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Capital Markets initiates Envoy Medical stock with buy rating By Investing.com - Investing.com Canada
Envoy Medical Inc (COCH) Cash Flow - TradingKey
Envoy Medical Inc (COCH) Income Statement - TradingKey
Envoy Medical Inc (COCH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Envoy Medical Inc (COCH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Envoy Medical Inc (COCH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo Finance
Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant - Sahm
Exclusive: Envoy Medical builds momentum with improved cochlear implant trial results - MSN
Envoy Medical hits 3-month milestone in trial f... - Pluang
All 56 patients reach 3 months in Envoy Medical's hearing implant trial - Stock Titan
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. I - GuruFocus
Enterprise value to revenue forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN) - ACCESS Newswire
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Envoy Medical Inc Warrant (COCHW) Surges 36.7%: A Volatile Move Near Key LevelsATR Trailing Stop - dars.gov.et
Frontier tech research, news & data - MLQ.ai
H.C. Wainwright Maintains Envoy Medical(COCH.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo
H.C. Wainwright reiterates Envoy Medical stock rating on trial progress By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Envoy Medical stock rating on trial progress - Investing.com
COCH Reiterated by HC Wainwright & Co. -- Price Target Maintained at $2.50 - GuruFocus
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results - Sahm
Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts - FinancialContent
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant - TMX Newsfile
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group - Newswire.com
Envoy Medical (COCH) Rebounds Sharply: Key Levels and Technical OutlookCall Flow Alert - dars.gov.et
COCHEnvoy Medical Inc Earnings - Finviz
Envoy Medical, Inc. Warrant 2021-22.04.26 on Envoy Med-A Financial Disclosures & SEC Filings - TradingView
Insiders Of Envoy Medical Are Up 98% On Their US$8.17m Purchase - simplywall.st
Envoy Medical Ends ATM Equity Program Amid Capital Confidence - TipRanks
Envoy Medical Terminates At-The-Market Offering Agreement - TradingView
Envoy Medical (NASDAQ: COCH) terminates $15 million ATM equity facility - Stock Titan
Envoy Medical submits first module of PMA to FDA for implant - Investing.com South Africa
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device - TMX Newsfile
Envoy Medical starts FDA review of its breakthrough hearing device - Stock Titan
COCH Forecast — Price Target — Prediction for 2027 - TradingView
Envoy Medical, Inc. Class A Actuals & Estimates (BOATS:COCH) - TradingView
Envoy Medical boosts CEO Brent Lucas compensation with salary, bonus and equity awards - TradingView
Envoy Medical (NASDAQ: COCH) ties major CEO RSU grant to FDA approval - Stock Titan
Envoy Medical terminates $15 million equity offering facility - Investing.com
COCH: Fully implanted cochlear implant advances toward FDA approval, targeting a vast unmet market - TradingView
Envoy Medical Terminates At-the-Market (ATM) Equity Facility - TMX Newsfile
Envoy Medical terminates $15 million equity offering facility By Investing.com - Investing.com Canada
Envoy Medical shuts down its $15M stock-sale facility - Stock Titan
Envoy Medical ends $15M at-the-market equity fa... - Pluang
Form 4 Envoy Medical Inc For: 23 June By Investing.com - Investing.com Nigeria
Finanzdaten der Envoy Medical Inc-Aktie (COCH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Envoy Medical Inc-Aktie (COCH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):